A study of a new medicine for high cholesterol
Treatments studied
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests if a new drug, QLC7401, can lower cholesterol in people with high cholesterol who are not on other cholesterol medicines. It may be an option if you have low or medium risk of heart disease and no history of heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your fasting LDL cholesterol is between 2.6 and 4.9 mmol/L.
- You are not currently taking any cholesterol-lowering medication.
- Your kidney function is above a certain level (eGFR over 30).
- You do not have a type of high cholesterol that runs in families (familial hypercholesterolemia).
- You have not had a heart attack or stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.
This trial tests an experimental drug, QLC7401, for people with high LDL cholesterol that hasn't lowered enough with current treatments. It aims to see if the drug can help reduce cholesterol levels in patients who are already on stable cholesterol medication.
This study tests how a new drug moves through the body and affects cholesterol levels. It is for people with moderately high cholesterol who are otherwise healthy.
This trial tests an experimental medication called QLC7401 for people with a genetic condition that causes very high cholesterol. It aims to lower cholesterol levels safely and may be an option for those who need better control.
This trial tests a new drug called HS-10582 in healthy people and those with slightly high LDL cholesterol (a type of cholesterol). The goal is to see if it is safe and how well your body handles it.
This trial tests a new investigational medicine (SYH2053) for people with high cholesterol or mixed hyperlipidemia who are already on cholesterol-lowering therapy but still have high levels of 'bad cholesterol' (LDL-C). The goal is to see if this add-on treatment can help lower cholesterol further and reduce heart disease risk.
Hear when a new Primary Hypercholesterolemia or Mixed Hyperlipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.